Clinical Data Associate at HeartFlow

San Francisco, California, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Medical Technology, Healthcare InnovationIndustries

Requirements

Candidates must have demonstrated experience managing different types of data for clinical trials, possess exceptional organizational skills, and exhibit excellent attention to detail. They should be comfortable working in a fast-paced start-up culture and have knowledge of ICH Guidelines, US FDA, and European clinical trial requirements and regulations. The ability to manage multiple tasks with shifting priorities, high attention to detail, accuracy, and quality, and flexibility to learn new techniques are also essential.

Responsibilities

The Clinical Data Associate is responsible for the oversight and management of all clinical data activities for clinical trials, including developing timelines for data management, enrollment projections, and creating instructional materials. They will oversee the development and user acceptance testing of clinical databases, upload cases, and enter biometrics. Responsibilities also include participating in process improvement activities, SOP development, assisting with study start-up, examining and resolving data inconsistencies, and maintaining relationships with investigators, site coordinators, and vendors. The CDA will act as the point of contact for data management in study meetings and may travel for investigator meetings or vendor visits.

Skills

Clinical Data Management

Clinical Trials

Data Management

Organizational Skills

Attention to Detail

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free